astria therapeutics glp-1 receptor agonist weight management diabetes treatments cardinal health GLP-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon How GLP-1 Receptor Agonists Evolved
Description
The past several decades have been boom times for innovation across multiple CVD risk factors, bringing forth an abundance of medications to regulate lipids, control blood pressure, lower blood sugar and improve inflammation
Even patients who initially access treatment through coverage may face interruptions if policies change, if prior authorizations are denied, or if employers revise benefits
Type 1 diabetes is characterised by deficient insulin production by the pancreas
Since then, research has continued, leading to newer, often more effective, and longer-acting versions
Letarouilly, J
